Novel coatings on titanium implants for the delivery of stem cells
用于输送干细胞的钛植入物上的新型涂层
基本信息
- 批准号:8392335
- 负责人:
- 金额:$ 14.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-15 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipose tissueAffinityAgeAnimal ModelAnimalsAntibodiesAreaAspirate substanceAutologousBindingBiocompatibleBlood PlateletsBlood VesselsBone GrowthBone MarrowBone Marrow Stem CellBone RegenerationCalvariaCell AdhesionCell CountCell ProliferationCell SeparationCellsClinicClinicalContainmentDataDefectElasticityFiberFrequenciesGoalsGoldGrowth FactorHarvestHealedImmune responseImplantLinkMeasuresMesenchymal Stem CellsModelingModificationOperative Surgical ProceduresOralOsseointegrationOsteogenesisOutcomePeptidesPhage DisplayPharmaceutical PreparationsPhasePhenotypeProcessProliferatingRattusSafetyScreening procedureShapesSiteSolutionsSpecificityStem cellsSurfaceSurgeonSurgical FlapsTechnologyTestingTherapeuticTimeTissuesTitaniaTitaniumTumor Tissueadult stem cellbiomaterial compatibilitybonecell motilitycell typecraniofacialcraniomaxillofacialcraniumdesignhealingimplantationimprovedin vivomacrophagenovelosteogenicpreventprotein aminoacid sequencereconstructionrestorationscaffoldsuccess
项目摘要
DESCRIPTION (provided by applicant): Calvarial reconstruction continues to present challenges for surgeons. Although the gold standard for restoration of the skull is autologous bone, particularly from the removed flap, substitutes are often necessary due to the flap becoming infected or infiltrated with tumor tissue. Other challenges to the use of the removed flap include age, difficulties with storage, surgery timing, and anatomical conditions. Therefore, the surgeon often relies on alloplastic materials such as titanium mesh, which can be easily shaped, has a modulus of elasticity similar to bone, and is biocompatible. However, titanium mesh does not provide the cells or growth factors needed to stimulate bone regeneration. One approach for bone regeneration is the combination of a scaffold with osteogenic cells to accelerate healing by reducing the need for endogenous cell migration and proliferation at the implant site. Adipose-derived and bone marrow-derived mesenchymal stem cells (ASCs and BMSCs, respectively) have shown potential to support bone growth in multiple models of bone defects and craniofacial reconstruction. Currently, ASCs and BMSCs are purified through culture expansion or through tedious negative or positive selections with antibodies. The difficulty achieving therapeutic numbers of cells and the complicated processing steps involved in their isolation have limited the use of stem cells in the clinic. To address this unmet need, Affinergy used phage display screening to identify peptide sequences that bind stem cells with high affinity. In this application, we propose to test the feasibility of modifying the surface of titanium with this peptide to improve the capture and retention of stem cells. The technology will significantly improve outcomes for oral and craniomaxillofacial surgeries with titanium implants.
PUBLIC HEALTH RELEVANCE: Calvarial reconstruction continues to present challenges for surgeons. One proposed solution is the use of adult stem cells to augment bone regeneration; however, the use of stem cells has been limited by the low frequency of the cells in tissue. In this application, we propose to develop a titanium implant that can capture and retain adult stem cells to improve clinical outcomes.
描述(由申请人提供):颅骨重建继续给外科医生带来挑战。虽然颅骨修复的金标准是自体骨,特别是来自切除的皮瓣,但由于皮瓣被肿瘤组织感染或浸润,通常需要替代品。使用移除的皮瓣的其他挑战包括年龄、储存困难、手术时机和解剖条件。因此,外科医生经常依赖钛网等同种异体材料,这种材料易于成型,具有与骨骼相似的弹性模量,并且具有生物相容性。然而,钛网不提供刺激骨再生所需的细胞或生长因子。骨再生的一种方法是将支架与成骨细胞相结合,通过减少植入部位内源细胞迁移和增殖的需要来加速愈合。脂肪来源和骨髓来源的间充质干细胞(分别为 ASC 和 BMSC)已显示出在多种骨缺损和颅面重建模型中支持骨生长的潜力。 目前,ASC 和 BMSC 是通过培养扩增或通过繁琐的抗体阴性或阳性选择来纯化的。获得治疗数量的细胞的困难以及分离细胞所涉及的复杂的处理步骤限制了干细胞在临床中的使用。为了解决这一未满足的需求,Affinergy 使用噬菌体展示筛选来鉴定以高亲和力结合干细胞的肽序列。在此应用中,我们建议测试用这种肽修饰钛表面以改善干细胞捕获和保留的可行性。该技术将显着改善钛种植体口腔和颅颌面手术的效果。
公共卫生相关性:颅骨重建继续给外科医生带来挑战。一种提议的解决方案是使用成体干细胞来增强骨再生。然而,干细胞的使用受到组织中细胞频率低的限制。在此应用中,我们建议开发一种钛植入物,可以捕获并保留成体干细胞,以改善临床结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martyn Darby其他文献
Martyn Darby的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martyn Darby', 18)}}的其他基金
A novel peptide assay for hepcidin clinical monitoring
一种用于铁调素临床监测的新型肽测定方法
- 批准号:
10698746 - 财政年份:2023
- 资助金额:
$ 14.98万 - 项目类别:
A Rapid Point of Care Test for APOL1 Renal Risk Alleles
APOL1 肾脏风险等位基因的快速护理检测
- 批准号:
10257344 - 财政年份:2021
- 资助金额:
$ 14.98万 - 项目类别:
A Rapid Point of Care Test for APOL1 Renal Risk Alleles
APOL1 肾脏风险等位基因的快速护理检测
- 批准号:
10441565 - 财政年份:2021
- 资助金额:
$ 14.98万 - 项目类别:
Rapid assay to monitor vancomycin levels at the point of care in hemodialysis patients
快速测定血液透析患者护理点万古霉素水平
- 批准号:
10398206 - 财政年份:2020
- 资助金额:
$ 14.98万 - 项目类别:
Rapid assay to monitor vancomycin levels at the point of care in hemodialysis patients
快速检测血液透析患者护理点万古霉素水平
- 批准号:
10163177 - 财政年份:2020
- 资助金额:
$ 14.98万 - 项目类别:
Immunoprofiling to develop a novel diagnostic array for cardiac sarcoidosis
免疫分析用于开发心脏结节病的新型诊断阵列
- 批准号:
9907835 - 财政年份:2020
- 资助金额:
$ 14.98万 - 项目类别:
Rapid assay to monitor vancomycin levels at the point of care in hemodialysis patients
快速检测血液透析患者护理点万古霉素水平
- 批准号:
10058954 - 财政年份:2020
- 资助金额:
$ 14.98万 - 项目类别:
Novel assay to monitor Tacrolimus levels at the point of care
在护理点监测他克莫司水平的新方法
- 批准号:
10203792 - 财政年份:2018
- 资助金额:
$ 14.98万 - 项目类别:
Novel PhageLock assay to measure hepcidin for clinical monitoring
新型 PhageLock 测定法可测量铁调素以进行临床监测
- 批准号:
9462254 - 财政年份:2017
- 资助金额:
$ 14.98万 - 项目类别:
Peptide-based tool for the rapid isolation of quiescent monocytes from peripheral blood
用于从外周血中快速分离静态单核细胞的基于肽的工具
- 批准号:
9340352 - 财政年份:2017
- 资助金额:
$ 14.98万 - 项目类别:
相似国自然基金
YTHDC1调控棕色脂肪组织大小、发育和能量代谢的作用机制研究
- 批准号:32371198
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
糖尿病脂肪组织中SIRT3表达降低进而上调外泌体miR-146b-5p促进肾小管脂毒性的机制研究
- 批准号:82370731
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于ADPN-Cer轴的柑橘黄酮调控能量负平衡奶牛脂肪组织脂解的分子机制
- 批准号:32302767
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ANGPTLs基因及其蛋白表达水平调控内脏脂肪组织影响健康衰老表型的前瞻性队列研究
- 批准号:82373661
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Acvrl1调控脂肪组织巨噬细胞M1/M2极化改善肥胖的机制研究
- 批准号:82300973
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
- 批准号:
10733720 - 财政年份:2023
- 资助金额:
$ 14.98万 - 项目类别:
Molecular and cellular analysis of the ABHD5/PNPLA3 metabolon in lipid homeostasis
ABHD5/PNPLA3 代谢在脂质稳态中的分子和细胞分析
- 批准号:
10296888 - 财政年份:2021
- 资助金额:
$ 14.98万 - 项目类别:
TRANSCRIPTIONAL REGULATION OF BEIGE ADIPOCYTE CELLULAR PLASTICITY
米色脂肪细胞可塑性的转录调控
- 批准号:
10276132 - 财政年份:2021
- 资助金额:
$ 14.98万 - 项目类别:
TRANSCRIPTIONAL REGULATION OF BEIGE ADIPOCYTE CELLULAR PLASTICITY
米色脂肪细胞可塑性的转录调控
- 批准号:
10445307 - 财政年份:2021
- 资助金额:
$ 14.98万 - 项目类别:
Molecular and cellular analysis of the ABHD5/PNPLA3 metabolon in lipid homeostasis
ABHD5/PNPLA3 代谢在脂质稳态中的分子和细胞分析
- 批准号:
10453590 - 财政年份:2021
- 资助金额:
$ 14.98万 - 项目类别: